Chinese and Western medicine for rheumatoid arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study combines traditional Chinese medicine with Western medicine to treat rheumatoid arthritis. It aims to see how well this approach works for people with hard-to-treat RA or RA-related lung disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You need a diagnosis of rheumatoid arthritis using standard medical criteria.
- If your RA is difficult to treat, it must meet specific guidelines for hard-to-treat RA.
- If you have RA-related lung disease, both a rheumatologist and a lung doctor must confirm it.
- You must be willing to receive traditional Chinese medicine treatments.
- You cannot have serious health issues like cancer, severe lung problems, or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial combines traditional Chinese herbal medicine with standard Western treatments for people with rheumatoid arthritis that hasn't responded well to at least two prior medications. It aims to see if the combination is more effective and safe.
This study tests a treatment plan for people who have rheumatoid arthritis and interstitial lung disease (scarring in the lungs). The goal is to find the best way to treat both conditions together and slow lung damage.
This study tests an investigational drug called TLL-018 for people with moderate to severe rheumatoid arthritis who have not improved enough with standard disease-modifying drugs. It aims to see if the drug can reduce joint pain and swelling.
This trial tests a new drug called telitacicept for people with rheumatoid arthritis (RA) that hasn't been controlled by multiple standard treatments. It aims to see if telitacicept can help reduce inflammation and improve symptoms.
This trial tests a Chinese herbal formula (Bushen Quhan Zhiwang decoction) to help people with rheumatoid arthritis who also have a pattern of 'kidney deficiency and excessive cold' achieve deeper remission. It may be an option if your disease is mild to moderate and you are on a stable single medication.
This trial tests a combination of a traditional Chinese medicine (Huoluo Pills) and a Western drug (iguratimod) for people with moderate rheumatoid arthritis. It aims to see if the combination works better than either treatment alone.
Hear when a new Rheumatoid Arthritis-Associated Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.